TIMENTIN IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Timentin In Plastic Container, and when can generic versions of Timentin In Plastic Container launch?
Timentin In Plastic Container is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in TIMENTIN IN PLASTIC CONTAINER is clavulanate potassium; ticarcillin disodium. There are twenty-seven drug master file entries for this compound. Additional details are available on the clavulanate potassium; ticarcillin disodium profile page.
Summary for TIMENTIN IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 10 |
Clinical Trials: | 1 |
Patent Applications: | 144 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TIMENTIN IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for TIMENTIN IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Osprey Medical, Inc | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for TIMENTIN IN PLASTIC CONTAINER
US Patents and Regulatory Information for TIMENTIN IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | TIMENTIN IN PLASTIC CONTAINER | clavulanate potassium; ticarcillin disodium | INJECTABLE;INJECTION | 050658-001 | Dec 15, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |